Baxter expects to reach 100% allocation across several IV product codes by the end of 2023. The company plans to increase production capacity through phased updates in late November, mid-December and ...

Most of Nashville's hospitals have a healthy supply of fluids, but they are continuing to assess sometimes daily and search ...

Otsuka Holdings will pay ICU Medical an upfront payment of $200 million. The U.S. IV products market has seen ...

The global dialysis equipment market is on a strong growth trajectory, with projected sales expected to increase from USD ...

However, CEO Joe Almeida stressed that the earliest that new products could start to ship from the plant is late November.

Q3 2024 Earnings Call Transcript November 8, 2024 Operator: Good morning, ladies and gentlemen, and welcome to Baxter ...

Baxter, a health care solutions manufacturer headquartered in Illinois, has been making progress on reopening one of its ...

Baxter said it is working to restore production at the facility, but does not have a targeted date for getting it back up to full capacity. The highest output production line at the factory, which ...

Baxter International (BAX) stock slips as the company with its Q3 2024 results lowers guidance to reflect a $200M revenue hit ...

The company, which is a key producer for American healthcare providers, was hit by the hurricane when it tore through western ...

Baxter expects to restart a second IV solutions manufacturing line within the next week, the company announced Nov. 7. Along ...

Hospitals across North Texas continue to conserve supplies to avoid procedure delays as a nationwide IV fluid shortage tests ...